MediBuddy partners with Japan’s ELECOM

IMT News Desk
IMT News Desk
· 2 min read

IOT-enabled smart health devices will be launched to enhance preventive healthcare in India

The digital transformation to empower millions of Indians to take charge of their well-being through accessible, data-driven health monitoring

MediBuddy announced a strategic partnership with ELECOM, a leading Japanese electronics company, to jointly develop and introduce cutting-edge smart health IOT devices to the Indian market. In the initial phase, the partnership will focus on launching integrated healthcare solutions through ELECOM’s products, enhancing accessibility across India.

MediBuddy aims to deliver more targeted interventions and improve health outcomes across the country by making daily health management more convenient. All medical records will automatically integrate into the MediBuddy app enabling the doctor to improve patient wellbeing.

Satish Kannan, CEO and Co-founder, MediBuddy said, “MediBuddy’s vision has always been at the forefront of healthcare innovation in India. Digital healthcare will be the way forward to enable -quality healthcare reaching billions of people. Preventive healthcare is critical for a large population to lead a healthy lifestyle, especially with the rising incidence of non-communicable diseases (NCD) in India. We aim to provide solutions that simplify patients’ ability to track and adopt healthy habits. Through this partnership, we are combining MediBuddy’s unparalleled Pan-India reach and deep healthcare expertise with ELECOM’s world-class IoT technology to create a seamless healthcare ecosystem. This collaboration marks a significant step towards making preventive healthcare accessible, intuitive, and personalised for every Indian.”

The partnership will also extend to jointly developing products tailored to India’s unique healthcare landscape, such as weighing scales, body composition scales, blood pressure monitors etc which are essential for daily health management.

Dr Kota Hada, CEO Healthcare Division, Elecom, said, “The partnership with MediBuddy is a crucial step towards realising our Healthcare Business Division’s vision of delivering medical and healthcare services. In India, lifestyle-related diseases have become a serious social issue, and from a medical standpoint, early prevention and management are considered extremely important. In this initiative, we plan to provide a system for seamlessly managing users’ health data, utilising our IoT technology, including Wi-Fi-enabled and Bluetooth-equipped weight and body composition scales. This will enable the creation of preventive programs tailored to each user’s health condition, aiming to bridge the gap between medical care and daily life. Leveraging our experience as healthcare professionals, we are committed to contributing to the health improvement of people in India and supporting better living.”

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk